a) Can hypothermia be achieved efficiently to potentially impact ischemic and reperfusion injury cascades in ischemic stroke?

b) Which biochemical pathways lead to early injuries during reperfusion?

c) Why have human trials failed to show benefits of hypothermia while animal models have demonstrated a robust clinical effect?